OncLive® Presents State of the Science Summit™ on Hematologic Malignancies - April 25, 2019

CRANBURY, N.J.--(BUSINESS WIRE)-- OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to deliver the best patient care, will host its latest State of the Science Summit™ on hematologic malignancies on Wednesday, May 1, from 5-9 p.m. at the DoubleTree by Hilton Hotel Raleigh-Durham Airport in North Carolina. The summit will be co-chaired by Harry Paul Erba, M.D., PhD, director of the leukemia program, director of phase 1 development in hematologic malignancies, and instructor in the department of medicine, Duke Cancer Institute, and Cristina Gasparetto, M.D., cell therapy and hematologic malignancies specialist, Duke Cancer Institute.

This interactive and educational meeting will discuss novel treatments for patients with hematologic malignancies. The expert presenters will delve into informative topics facing hematologic malignancies specialists, oncologists, nurses and other medical professionals, such as Hodgkin and non-Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia, acute lymphocytic leukemia, chronic myeloid leukemia, and treatment of severe aplastic anemia, as well as the latest updates in chimeric antigen receptor T-cell therapy. The presenters will also engage in a peer exchange and address audience questions.

Presenters for the summit include the following experts from the Duke Cancer Institute:

• Dr. Danielle Brander, cell therapy and hematologic malignancies specialist and assistant professor of medicine
• Dr. Nelson Chao, Donald D. and Elizabeth G. Cooke Cancer Research Professor; chief, division of cell therapy; and professor of medicine in immunology and pathology
• Dr. Carlos de Castro, cell therapy and hematologic malignancies specialist and professor of medicine
• Dr. Ahmed Galal, cell therapy and hematologic malignancies specialist
• Dr. Yubin Kang, cell therapy and hematologic malignancies specialist, medical oncologist, and professor of medicine
• Dr. Tom LeBlanc, cell therapy and hematologic malignancies specialist, hematologist, medical oncologist, palliative medicine specialist, and associate professor of medicine
• Dr. Matt McKinney, cell therapy and hematologic malignancies specialist
• Dr. Lindsay Rein, cell therapy and hematologic malignancies specialist
• Dr. David Rizzieri, cell therapy and hematologic malignancies specialist

State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.

Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit https://www.onclive.com/meetings/soss or contact Kayla Collins at kcollins@onclive.com.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates, Inc., is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190425005861/en/